The global major depressive disorder (MDD) treatment market is expected to experience steady growth, projected to develop at ...

on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

A light at the end of the dark tunnel of depression? Doctors commonly prescribe antidepressants to treat patients suffering ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

Bright light therapy, a standard treatment for seasonal depression, may also help people who experience depression year-round ...

de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revoluti ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can ...

Although bipolar disorder is a chronic mental health condition, treatments are available ... which have the same symptoms that people with major depressive disorder experience.

Cybin launches Phase 3 trials for CYB003, aiming to offer lasting relief for Major Depressive Disorder. Backed by promising ...